NCT03834844

Brief Summary

The aim of this project is to determine whether the entire intervention (Mindfulness meditation, AF education, and weekly phone visits) that is nurse delivered to individuals with paroxysmal atrial fibrillation is more effective than a combination, single or no intervention in the reduction of overall AF symptoms, anxiety, and negative illness perception; or the improvement of quality of life (QOL) and functional status.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 8, 2019

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 2, 2024

Status Verified

November 1, 2024

Enrollment Period

6.7 years

First QC Date

February 6, 2019

Last Update Submit

November 27, 2024

Conditions

Keywords

Symptom ManagementQuality of LifeAnxiety

Outcome Measures

Primary Outcomes (6)

  • Change from Baseline Atrial Fibrillation Symptom Burden and Symptom Severity Scores

    Atrial Fibrillation Burden and Symptom Severity will be calculated from the patient-completed responses on the Atrial Fibrillation Symptom Severity Scale-Symptom Burden can range from 3.25 (minimally bothersome) to 30 (continuous symptomatic episodes) and is based on event frequency (1-10), duration (1.25-10), and global episode (1-10). Symptom severity is based on symptom specific subscale with range from 0(no symptoms) to 35 (severe symptoms).

    Baseline (Initial), Post-Intervention (6 weeks)

  • Change from Baseline Atrial Fibrillation Symptom Burden and Symptom Severity Scores

    Atrial Fibrillation Burden and Symptom Severity will be calculated from the patient-completed responses on the Atrial Fibrillation Symptom Severity Scale-Symptom Burden can range from 3.25 (minimally bothersome) to 30 (continuous symptomatic episodes) and is based on event frequency (1-10), duration (1.25-10), and global episode (1-10). Symptom severity is based on symptom specific subscale with range from 0(no symptoms) to 35 (severe symptoms).

    Baseline (Initial), 6 month

  • Change from Baseline Atrial Fibrillation Symptom Burden and Symptom Severity Scores

    Atrial Fibrillation Burden and Symptom Severity will be calculated from the patient-completed responses on the Atrial Fibrillation Symptom Severity Scale-Symptom Burden can range from 3.25 (minimally bothersome) to 30 (continuous symptomatic episodes) and is based on event frequency (1-10), duration (1.25-10), and global episode (1-10). Symptom severity is based on symptom specific subscale with range from 0(no symptoms) to 35 (severe symptoms).

    Baseline (Initial), 12 month

  • Change from Baseline in AF Quality of Life Score

    Quality of Life will be assessed using a patient completed questionnaire, Atrial Fibrillation Effect on Quality of Life Questionnaire. The AFEQT score is a combined score of 21 items (21-100) with a higher score representing greater QOL.

    Baseline (Initial), Post-Intervention (6 weeks)

  • Change from Baseline in AF Quality of Life Score

    Quality of Life will be assessed using a patient completed questionnaire, Atrial Fibrillation Effect on Quality of Life Questionnaire. The AFEQT score is a combined score of 21 items (21-100) with a higher score representing greater QOL.

    Baseline (Initial), 6 month

  • Change from Baseline in AF Quality of Life Score

    Quality of Life will be assessed using a patient completed questionnaire, Atrial Fibrillation Effect on Quality of Life Questionnaire. The AFEQT score is a combined score of 21 items (21-100) with a higher score representing greater QOL.

    Baseline (Initial), 12 month

Secondary Outcomes (3)

  • Change from Baseline in Anxiety

    Baseline (Initial), Post-Intervention (6 weeks)

  • Change from Baseline in Anxiety

    Baseline (Initial), 6 months

  • Change from Baseline in Anxiety

    Baseline (Initial), 12 months

Study Arms (8)

Usual Care

NO INTERVENTION

patient receives same care as patients not enrolled in study intervention

AF education

EXPERIMENTAL

Participant receives 6 modules of AF education topics that are intended to be completed consecutively, one each week.

Other: AF Education

Mindfulness Meditation Practice

EXPERIMENTAL

Each participant watches an mindfulness meditation introductory video in the initial session and then is asked to practice for 10 minutes each day using a guided audio, which includes a different topic each week. The time duration of the guided meditations increases to 15 minutes each day during Weeks 3-6.

Behavioral: Meditation

Weekly Phone Calls

EXPERIMENTAL

Each week for the six-week intervention, the researcher will contact the participant by phone at an agreed upon time and will discuss any questions, issues or concerns that are voiced by the participant within 5-15 minutes.

Other: Phone Calls

AF Education and Mindfulness Meditation

EXPERIMENTAL

Participant receives 6 modules of AF education topics that are intended to be completed consecutively, one each week. Each participant watches an mindfulness meditation introductory video in the initial session and then is asked to practice for 10 minutes each day using a guided audio, which includes a different topic each week. The time duration of the guided meditations increases to 15 minutes each day during Weeks 3-6.

Behavioral: MeditationOther: AF Education

AF Education and Weekly Phone Calls

EXPERIMENTAL

Participant receives 6 modules of AF education topics that are intended to be completed consecutively, one each week. Each week for the six-week intervention, the researcher will contact the participant by phone at an agreed upon time and will discuss any questions, issues or concerns that are voiced by the participant within 5-15 minutes.

Other: AF EducationOther: Phone Calls

Mindfulness Meditation and Phone Calls

EXPERIMENTAL

Each participant watches an mindfulness meditation introductory video in the initial session and then is asked to practice for 10 minutes each day using a guided audio, which includes a different topic each week. The time duration of the guided meditations increases to 15 minutes each day during Weeks 3-6. Each week for the six-week intervention, the researcher will contact the participant by phone at an agreed upon time and will discuss any questions, issues or concerns that are voiced by the participant within 5-15 minutes.

Behavioral: MeditationOther: Phone Calls

Meditation and Education and Phone Calls

EXPERIMENTAL

Each participant watches an mindfulness meditation introductory video in the initial session and then is asked to practice for 10 minutes each day using a guided audio, which includes a different topic each week. Participant receives 6 modules of AF education topics that are intended to be completed consecutively, one each week. The time duration of the guided meditations increases to 15 minutes each day during Weeks 3-6. Each week for the six-week intervention, the researcher will contact the participant by phone at an agreed upon time and will discuss any questions, issues or concerns that are voiced by the participant within 5-15 minutes.

Behavioral: MeditationOther: AF EducationOther: Phone Calls

Interventions

MeditationBEHAVIORAL

Guided Meditation for 10-15 minutes daily for 6 days/week for 6 weeks

AF Education and Mindfulness MeditationMeditation and Education and Phone CallsMindfulness Meditation PracticeMindfulness Meditation and Phone Calls

6 weekly education modules on topics related to AF

AF Education and Mindfulness MeditationAF Education and Weekly Phone CallsAF educationMeditation and Education and Phone Calls

Weekly phone call to discuss patient concerns or questions

AF Education and Weekly Phone CallsMeditation and Education and Phone CallsMindfulness Meditation and Phone CallsWeekly Phone Calls

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsAll
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals with Symptomatic Paroxysmal Atrial Fibrillation
  • A symptomatic episode of PAF within last 6 months
  • years old or greater
  • Able to read and understand English
  • Able to participate in weekly phone calls
  • Able to attend two video visit/phone sessions that are 6 weeks apart

You may not qualify if:

  • Diagnosed with low cardiac function (NYHA Class IV)
  • Life expectancy of less than 6 months
  • Hospitalized in prior 3 months for illness other than PAF
  • Previously practiced mindfulness
  • Cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford Health Care

Stanford, California, 94305, United States

Location

MeSH Terms

Conditions

Atrial FibrillationAnxiety Disorders

Interventions

Meditation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsSpiritual TherapiesRelaxation TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Linda Ottoboni, PhD

    Clinician and research scientist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: 2 x 2 factorial design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

February 6, 2019

First Posted

February 8, 2019

Study Start

May 1, 2018

Primary Completion

December 31, 2024

Study Completion

December 31, 2025

Last Updated

December 2, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations